Trial Profile
A Two-Stage, Open-Label, Randomized, Crossover Study Evaluating the Pharmacokinetics of Single Doses of Two Investigational Rifaximin Soluble Solid Dispersion Formulations (Immediate Release and Sustained Extended Release) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 May 2018
Price :
$35
*